Parallel Industries (OTCMKTS:EAPH – Get Free Report) is one of 237 public companies in the “Drug Manufacturers—Specialty & Generic” industry, but how does it weigh in compared to its peers? We will compare Parallel Industries to similar companies based on the strength of its risk, earnings, valuation, analyst recommendations, institutional ownership, dividends and profitability.
Analyst Ratings
This is a breakdown of current ratings and price targets for Parallel Industries and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Parallel Industries | 0 | 0 | 0 | 0 | N/A |
| Parallel Industries Competitors | 207 | 1004 | 2280 | 42 | 2.61 |
As a group, “Drug Manufacturers—Specialty & Generic” companies have a potential upside of 14.28%. Given Parallel Industries’ peers higher possible upside, analysts clearly believe Parallel Industries has less favorable growth aspects than its peers.
Valuation and Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Parallel Industries | N/A | N/A | 0.00 |
| Parallel Industries Competitors | $3.80 billion | -$3.06 million | 110.89 |
Parallel Industries’ peers have higher revenue, but lower earnings than Parallel Industries. Parallel Industries is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Institutional and Insider Ownership
24.2% of shares of all “Drug Manufacturers—Specialty & Generic” companies are held by institutional investors. 26.4% of shares of all “Drug Manufacturers—Specialty & Generic” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Parallel Industries and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Parallel Industries | N/A | N/A | N/A |
| Parallel Industries Competitors | -86.81% | -60.20% | -11.69% |
Summary
Parallel Industries peers beat Parallel Industries on 5 of the 8 factors compared.
Parallel Industries Company Profile
Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada.
Receive News & Ratings for Parallel Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parallel Industries and related companies with MarketBeat.com's FREE daily email newsletter.
